A Leading CRDMO in Bioconjugates

Your Single Source for Bioconjugation Discovery, Development and Manufacturing

We are a fully integrated CRDMO specializing in bioconjugates, offering seamless, end-to-end solutions from discovery through to commercial manufacturing. Our one-stop comprehensive capabilities and innovative technology platform greatly simplifies bioconjugate development by providing lead screening and selection, preclinical activities, holistic and integrated CMC development, and the entire production supply chain. The truly single source empowers global partners to bring complex bioconjugate therapeutics to market with reduced time, cost and risks.

Our capabilities span from ADCs to XDCs

Novel bioconjugates extending beyond conventional ADCs pose unprecedented challenges and uncertainties due to their modality complexity. At WuXi XDC, we leverage innovative technology platform and integrated end-to-end solutions to navigate the entire process from discovery to manufacturing. Join us in transforming breakthrough ideas into impactful therapies and shaping the future of bioconjugates.

ADC/BsADC/Dual Payload ADC
Antibody-Oligonucleotide Conjugate
Antibody-Chelator Conjugate
Degrader Antibody Conjugate
Immuno-Stimulant Antibody Conjugate
Antibody-Peptide Conjugate

Vaccine Conjugate
PEGylation-Based Conjugate
Protein-Protein Conjugate
Antibody-Glycan Conjugate
Antibody-Fluorophore Conjugate
Peptide-Oligo Conjugate
and more…

Frontier Technology Platform for Bioconjugates

Conjugation and Payload-Linker Technology Innovation

The path to bioconjugates success demands precision—from DAR optimization and linker stability to rigorous safety profiling. At WuXi XDC, we recognize the transformative potential of bioconjugates and are committed to turning promise into reality. Leveraging our proprietary technologies, we have built a robust foundation for advanced bioconjugate development. Beyond our internal capabilities, we are actively forging and expanding partnerships with leading industry players. Through these collaborations, we continuously enrich and refine our technology platform, we don’t just support your journey—we propel it forward, accelerating breakthroughs at every stage.